Skip to main content

Table 1 Baseline patient characteristics

From: Risk factors for kidney injury during vancomycin and piperacillin/tazobactam administration, including increased odds of injury with combination therapy

Characteristica

N (%) [Mean, SD]

Years of age

[48.7, 15.3]

Male sex

148 (64.9)

Race

 African American

182 (79.8)

 Caucasian

34 (14.9)

 Hispanic

6 (2.6)

 Native Hawaiian

1 (0.4)

 Asian

2 (0.9)

 Native American

2 (0.9)

 Other

1 (0.4)

CrCl (ml/min) (n = 187)

[74.3, 32.8]

BMI (n = 187)

[26.8, 9.2]

Nephrotoxic agents

 IV contrast

50 (21.9)

 Aminoglycoside

8 (3.5)

 NSAID

31 (13.7)

 Tenofovir

13 (5.7)

 2 or more agents

17 (7.5)

Comorbidities

 Diabetes

49 (21.5)

 Hypertension

91 (39.9)

 Malignancy

16 (7.0)

 CKD

12 (5.3)

 HIV

50 (21.9)

 2 or more of the above comorbidities

65 (28.5)

Indication for antibiotics

 Sepsis unknown etiology

26 (11.8)

 Pneumonia

44 (19.3)

 Bacteremia

7 (3.1)

 Skin/soft tissue infection

76 (33.3)

 Intra-abdominal

20 (8.8)

 Central nervous system

2 (0.9)

 Urinary tract

9 (4.0)

 Bone/joint

41 (18.0)

  1. SD standard deviation
  2. an = 228 unless otherwise stated